Artificial intelligence radiology tech developer Qure.ai announced that it is working with the San Raffaele University Hospital in Milan to monitor disease progression in COVID-19 patients.

The Mumbai-based company’s QXR automated chest X-ray system is designed to interpret a coronavirus patient’s lung scans within seconds, quantifying how much of their lungs have been affected by the virus so clinicians can monitor disease progression with accuracy and efficiency.

QXR is designed to detect findings like ground-glass opacities and consolidation abnormalities that are indicative of coronavirus, according to a news release. The AI-powered system is also touted for detecting tuberculosis, chronic obstructive pulmonary disease, lung malignancies and medical emergencies including lung collapses and cardiac disorders.

“By using our technology, doctors can objectively monitor disease progression in a COVID-19 patient and their response to new therapeutic approaches,” Qure.ai CEO & co-founder Prashant Warier said in a news release.

“Our expertise with tackling tuberculosis has served us well in developing AI solutions to fight the COVID-19 pandemic. The algorithm we’ve created will help to reduce the workload of hospital staff, as well as to devise the best treatment options for patients, at different stages of COVID-19. We believe the technology will also help to aid in the discovery of new drugs and therapeutic approaches,” Warier concluded.